|
Name |
2,5-Cyclohexadiene-1,4-dione, 2-hydroxy-3,5,6-trimethyl-
|
| Molecular Formula | C9H10O3 | |
| IUPAC Name* |
4-hydroxy-3,5,6-trimethylcyclohexa-3,5-diene-1,2-dione
|
|
| SMILES |
CC1=C(C(=O)C(=O)C(=C1O)C)C
|
|
| InChI |
InChI=1S/C9H10O3/c1-4-5(2)8(11)9(12)6(3)7(4)10/h10H,1-3H3
|
|
| InChIKey |
WNWMTNXEYZAXOB-UHFFFAOYSA-N
|
|
| Synonyms |
SCHEMBL7287351; DTXSID201016321; 2913-43-1; 2-Hydroxy-3,5,6-trimethyl-1,4-quinone; 2,3,5-Trimethyl-6-hydroxy-1,4-benzoquinone; 2-Hydroxy-3,5,6-trimethylbenzo-1,4-quinone #; methyl-6-hydroxy-3,5-dimethyl-1,4-benzoquinone; 2,5-Cyclohexadiene-1,4-dione, 2-hydroxy-3,5,6-trimethyl-
|
|
| CAS | 2913-43-1 | |
| PubChem CID | 597139 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 166.17 | ALogp: | 0.4 |
| HBD: | 1 | HBA: | 3 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 54.4 | Aromatic Rings: | 1 |
| Heavy Atoms: | 12 | QED Weighted: | 0.441 |
| Caco-2 Permeability: | -5.134 | MDCK Permeability: | 0.00000799 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.979 |
| 30% Bioavailability (F30%): | 0.982 |
| Blood-Brain-Barrier Penetration (BBB): | 0.04 | Plasma Protein Binding (PPB): | 92.79% |
| Volume Distribution (VD): | 0.83 | Fu: | 8.52% |
| CYP1A2-inhibitor: | 0.702 | CYP1A2-substrate: | 0.405 |
| CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.096 |
| CYP2C9-inhibitor: | 0.078 | CYP2C9-substrate: | 0.396 |
| CYP2D6-inhibitor: | 0.043 | CYP2D6-substrate: | 0.204 |
| CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.109 |
| Clearance (CL): | 12.176 | Half-life (T1/2): | 0.924 |
| hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.088 |
| Drug-inuced Liver Injury (DILI): | 0.588 | AMES Toxicity: | 0.321 |
| Rat Oral Acute Toxicity: | 0.181 | Maximum Recommended Daily Dose: | 0.24 |
| Skin Sensitization: | 0.92 | Carcinogencity: | 0.39 |
| Eye Corrosion: | 0.012 | Eye Irritation: | 0.9 |
| Respiratory Toxicity: | 0.593 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002196 | ![]() |
0.481 | D0MM8N | ![]() |
0.231 | ||
| ENC003525 | ![]() |
0.465 | D03GET | ![]() |
0.222 | ||
| ENC000670 | ![]() |
0.465 | D0FA2O | ![]() |
0.222 | ||
| ENC005958 | ![]() |
0.429 | D0H6VY | ![]() |
0.222 | ||
| ENC002293 | ![]() |
0.419 | D0N0OU | ![]() |
0.217 | ||
| ENC003505 | ![]() |
0.344 | D0B9EJ | ![]() |
0.210 | ||
| ENC000909 | ![]() |
0.341 | D0Y0GH | ![]() |
0.203 | ||
| ENC000116 | ![]() |
0.333 | D0K7LU | ![]() |
0.197 | ||
| ENC000788 | ![]() |
0.311 | D0B3HD | ![]() |
0.196 | ||
| ENC002805 | ![]() |
0.305 | D0U4VT | ![]() |
0.196 | ||